Acadia Pharmaceuticals | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Acadia Pharmaceuticals USD 762M 80.42M 2025-06
ALKERMES USD 521.2M 121.39M 2025-06
Alnylam Pharmaceuticals USD 1.11B 94.03M 2025-06
Biogen USD 2.76B 160.5M 2025-06
BioMarin Pharmaceutical USD 1.21B 601.78M 2025-06
Bristol-Myers Squibb USD 12.6B 1.72B 2025-06
Corcept Therapeutics USD 102.74M 12.93M 2025-06
Cytokinetics USD 74.94M 863.28M 2025-06
Eisai JPY 265.56B 25.7B 2025-03
Eli Lilly USD 3.38B 282.6M 2025-06
Incyte USD 2.42B 13.08M 2025-06
J&J USD 38.47B 32.35B 2025-03
Moderna USD 1.28B 344M 2025-06
Neurocrine Biosciences USD 264M 69.9M 2025-06
Pfizer USD 1.64B 208M 2025-06
Prothena USD 471.39M 47.87M 2024-12
PTC Therapeutics USD 1.02B 1.01B 2025-06
Sarepta Therapeutics USD 510.6M 269.73M 2025-06
Ultragenyx Pharmaceutical USD 166.11M 396.9M 2025-06
Vertex Pharmaceuticals USD 6.38B 1.71B 2025-06


Acadia Pharmaceuticals Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.